首页> 美国卫生研究院文献>other >Modes of Delivery of Genetic Testing Services and the Uptake of Cancer Risk Management Strategies in BRCA1 and BRCA2 Carriers
【2h】

Modes of Delivery of Genetic Testing Services and the Uptake of Cancer Risk Management Strategies in BRCA1 and BRCA2 Carriers

机译:BRCA1和BRCA2携带者的基因检测服务提供方式和癌症风险管理策略的采用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BRCA testing services are now offered by various healthcare providers, thus it is important to evaluate whether the implementation of cancer risk management (CRM) strategies varies by service provider. Using a registry-based sample of 795 female BRCA mutation carriers, we explored the association between uptake of CRM strategies with duration of genetic counseling (GC) sessions, provider type, and other demographic and clinical variables. All participants completed a baseline questionnaire. Information about uptake of CRM strategies was collected for a subset of 438 participants who completed additional questions. Summary statistics and Pearson Chi square tests were used to examine the associations between demographic and clinical variables with service delivery factors and with the uptake of various CRM strategies. Overall uptake of CRM strategies was high across all provider types. However, GC sessions were longer when provided by a genetics professional than by another provider (p<0.001). Furthermore, higher frequencies of uptake of most CRM strategies were associated with longer GC sessions and when testing was done with involvement of a genetics professional. Identification of factors to optimize delivery of these specialized GC services is important to maximize implementation of CRM strategies in BRCA carriers.
机译:现在,各种医疗保健提供商都提供BRCA测试服务,因此评估癌症风险管理(CRM)策略的实施是否因服务提供商而异很重要。使用基于注册表的795个女性BRCA突变携带者的样本,我们探讨了CRM策略的摄取与遗传咨询(GC)会期,提供者类型以及其他人口统计学和临床​​变量之间的关系。所有参与者均完成了基线调查表。收集了有关438个参与者的CRM策略采用信息,这些参与者完成了其他问题。摘要统计和Pearson卡方检验用于检验人口统计学和临床​​变量与服务提供因素和采用各种CRM策略之间的关联。在所有提供商类型中,CRM策略的总体采用率很高。但是,由遗传学专业人士提供的GC会议要比其他提供者更长(p <0.001)。此外,大多数CRM策略的采用频率较高,这与更长的GC疗程以及在遗传学专业人员的参与下进行测试有关。确定优化这些专业GC服务交付的因素,对于最大限度地在BRCA运营商中实施CRM战略至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号